What Multi Channel Systems does

Multi Channel Systems MCS GmbH (MCS) is a German manufacturer of microelectrode array (MEA) electrophysiology systems, founded in 1996 and headquartered in Reutlingen, Baden-Württemberg. The company operates as a wholly-owned subsidiary of Harvard Bioscience, Inc. (NASDAQ: HBIO) and is grouped, with HEKA Elektronik and Warner Instruments, into Harvard Bioscience's Smart Ephys division serving pre-clinical research markets. MCS sells to academic neuroscience researchers, pharmaceutical and biotech drug discovery and safety pharmacology groups, and diabetes research institutions globally, with direct sales and e-commerce coverage in Europe, Australia, and New Zealand and third-party distributors elsewhere.

MCS's portfolio spans in vitro and in vivo electrophysiology. The core platform is the MEA2100 system family (60–256 electrodes, 24-bit A/D, integrated stimulation, temperature control, perfusion, DC–10 kHz bandwidth). Above it sits the CMOS-MEA5000 (4,225 recording electrodes and 1,024 stimulation sites on a 65×65 grid at 16–32 µm pitch, 25 kHz sampling) for sub-cellular resolution, and the Multiwell-MEA (24/96-well format, up to 1,152 electrodes, 50 kHz) for high-throughput screening. Specialized offerings include the Beta-Screen system for intact islet recordings in diabetes research, the Incub8 Multiwell MEA for combined optical and electrophysiological recording inside a CO2 incubator, the wireless W2100 and tethered ME2100 for in vivo work, and — since 2024 — the AcadeMEA entry-level system and MEA Xpress automated liquid-handling platform. The 2025 Mesh MEA (a 7 µm polyimide 60-electrode mesh enabling inside-organoid recordings) and the 2024 Foresee Biosystems IntraCell partnership (laser-based optoporation for intracellular action potentials) extend the portfolio into 3D and intracellular assays. Software (Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter and Analyzer) and a universal interface board (IFB-C, programmable DSP, USB 3.0) complete the workflow. Disposable MEAs in standard, CMOS, FlexMEA, and EcoFlexMEA variants, plus stimulus generators, perfusion, and micromanipulator accessories, supply the consumables and peripherals.

Revenue is generated through hardware system sales, recurring software licenses and 2-year service/maintenance plans, and disposable MEA consumables. Pricing is quote-based and gated to registered B2B accounts. The go-to-market combines a direct European/Australian field-sales motion (with 'Request a Demo' and 'Schedule a Meeting' CTAs), a B2B online shop, conference and webinar participation, and a worldwide distributor network outside direct territories. With 51–100 employees and a single R&D-and-manufacturing footprint, MCS runs a specialized, high-touch scientific-tools model where the installed base of instruments and consumable arrays drives recurring revenue.

Name

Multi Channel Systems

Legal name

Multi Channel Systems MCS GmbH

Website

https://multichannelsystems.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

51–100 employees

Short description

Multi Channel Systems MCS GmbH manufactures microelectrode array (MEA) electrophysiology systems, consumable electrode arrays, and software for neuroscience, pharmaceutical drug discovery, cardiotoxicity, and diabetes research. It is a wholly-owned subsidiary of Harvard Bioscience Inc. (NASDAQ: HBIO), headquartered in Reutlingen, Germany.

Ownership category

akta.pro rank

Product category

Electrophysiology Equipment

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Analytical Laboratory Instrument Manufacturing (334516), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Laboratory Analytical Instruments (3826), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)

akta.pro primary industry

Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)

akta.pro secondary industries

Sensor Fusion, Interface ICs & Modules (AFE/Readout/Packaging/Calibration) (HDAHALAO), Sensors, MEMS & Imaging ICs (HDAHAAAG)

Keywords

• Microelectrode array systems
• Electrophysiology equipment
• Neuroscience research instruments
• Cardiotoxicity screening tools
• In vivo recording systems

Headquarters

HQ city

Reutlingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. MEA Systems Hardware: Complete microelectrode array systems including amplifiers, headstages, interface boards, and data acquisition units for in vitro and in vivo electrophysiology research.
2. Microelectrode Arrays: Disposable MEA chips including standard, CMOS, FlexMEA, and specialized arrays. Electrodes include titanium nitride, gold, and PEDOT coatings with various layouts (24-4225 electrodes).
3. Software Licenses and Updates: Data acquisition and analysis software including Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, Beta-Screen Experimenter and Analyzer with maintenance packages.
4. Accessories and Consumables: Peripheral equipment including perfusion systems, micromanipulators, cables, chambers, replacement parts, and specialized accessories for specific applications.
5. Service Plans: MEA Systems Service Plans including software updates and support, typically offered as 2-year maintenance packages.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Multi Channel Systems designs, manufactures, and sells microelectrode array (MEA) systems and related electrophysiology instrumentation for in vitro and in vivo research, spanning complete recording platforms (MEA2100 family, CMOS-MEA5000, Multiwell-MEA, W2100 wireless, Beta-Screen), disposable microelectrode arrays, proprietary acquisition/analysis software, stimulus generators, perfusion equipment, and accessory hardware. Customers are primarily research institutions, pharmaceutical drug discovery labs, and universities conducting neuroscience, cardiac safety, and diabetes research.

Product overview

Multi Channel Systems (MCS) is a manufacturer of electrophysiology equipment specializing in microelectrode array (MEA) systems. The product portfolio centers on MEA2100-Systems (60-256 channels) and MEA2100-Mini-Systems for in vitro research, supplemented by high-throughput Multiwell-MEA-Systems (24/96-well, up to 1152 electrodes) and high-resolution CMOS-MEA5000-Systems (4225 electrodes, sub-cellular resolution). For specialized applications, MCS offers MEA2100-Beta-Screen-Systems for diabetes research and Incub8 for combined optical/electrophysiological recording in incubators. The portfolio also includes wireless (W2100) and tethered (ME2100) in vivo systems, stimulus generators (STG5, STG3000), perfusion equipment, and distributed brands from HEKA and Warner Instruments. Recent innovations include Mesh MEA for organoid research, IntraCell (laser-based optoporation for intracellular recordings), and AcadeMEA (entry-level system). All systems operate with proprietary Multi Channel Suite, Multiwell-Screen, CMOS-MEA-Control, and Beta-Screen software platforms.

Differentiator

Problem solved

Functional benefit

Products and services

• MEA2100-System Family Universal in vitro microelectrode array system for cardiac, neuronal, and stem cell applications with 60, 120, or 256 electrode configurations, integrated stimulation, temperature control, perfusion, and Multi Channel Suite software.
• MEA2100-Mini-System Compact MEA system with a small footprint designed to operate inside humidified CO2 incubators; records from 60-electrode MEAs with integrated heating and stimulation capabilities.
• Multiwell-MEA-System High-throughput in vitro system supporting standard 24- and 96-well plate formats with up to 1,152 electrodes and a 50 kHz sampling rate for drug screening and safety pharmacology applications.
• CMOS-MEA5000-System High-resolution in vitro electrophysiology system based on CMOS technology offering 4,225 recording electrodes and 1,024 stimulation sites with 25 kHz sampling for sub-cellular recordings; available with 16 or 32 µm sensor pitch.
• MEA2100-Beta-Screen-System In vitro recording system optimized for diabetes research with beta cells in intact islets of Langerhans, supporting up to 40 islets simultaneously with non-invasive medium-throughput screening capabilities.
• W2100-System (Wireless) All-in-one wireless in vivo recording and stimulation system with lightweight headstages (4-32 channels), electrical and optical stimulation options, and synchronized video-to-data recording for freely roaming animals.
• ME2100-System Tethered in vivo/ex vivo electrophysiology system with 32-256 recording channels, 24-bit A/D resolution, 50 kHz sampling rate, and electrical and optical stimulation options for brain research and Langendorff heart applications.
• Mesh MEA Microelectrode array chip with 60 electrodes on a 7µm-thin polyimide mesh that enables cells to grow around electrodes for true-to-life recordings from inside organoids without compromising structure.
• Incub8 Multiwell MEA System MEA system combining optical data with electrophysiological data in a single recording, operating from inside a humidified CO2 incubator for translatable and reproducible data.
• AcadeMEA Single-well MEA System Entry-level MEA system designed for labs focused on learning, discovery, and early-stage research, combining simplified hardware with MEA2100 platform performance of 60 or 120 channels.
• IntraCell Laser-based optoporation system by Foresee Biosystems that, when used with MCS MEA systems, allows capture of high-quality intracellular action potentials from both 2D cardiac monolayers and 3D cardiac organoids.
• IFB-C Interface Board Universal interface board with freely programmable DSP for real-time signal detection and feedback, up to 50 kHz sampling rate, and SuperSpeed USB 3.0 communication with up to three different headstage types.
• Microelectrode Arrays (MEAs) Disposable microelectrode arrays with 32, 60, 120, or 252 electrodes in various layouts including standard, multiwell plates (24 or 96 wells), CMOS arrays, and flexible FlexMEAs for different research applications.
• FlexMEA Flexible polyimide foil microelectrode arrays (EcoFlex and Standard versions) available with 24-72 electrodes; standard FlexMEAs (12µm thick) have titanium nitride electrodes and EcoFlexMEAs (50µm thick) have gold electrodes.
• CMOS-MEAs CMOS-based microelectrode arrays with 4,225 recording electrodes and 1,024 stimulation sites, available with 16µm or 32µm electrode spacing in a 65x65 grid, with or without culture/slice chambers.
• STG5 Stimulus Generator Stimulus generator for electrical and optical stimulation in electrophysiology experiments.
• STG3000 Series Programmable stimulus generator series used with MEA systems.
• Multi Channel Suite Software Free data acquisition software used with MEA2100 and W2100 systems.
• Beta-Screen Experimenter Software optimized for long-term experiments with beta cells in diabetes research (version 2.12.0).
• Beta-Screen Analyzer Software optimized for analyzing long-term experiments with beta cells in diabetes research (version 2.15.3).
• PPS2 Peristaltic Perfusion System Peristaltic perfusion system with two independent pumps for controlling fluid flow in electrophysiology experiments.
• CVP Constant Vacuum Pump Precision vacuum pump with a differential pressure sensor for pressure control in MEA systems.
• MEA Xpress Automated liquid handling robot with integrated Multiwell-MEA-System for streamlined workflow automation.
• Roboocyte2 Fully automated injection and TEVC system for Xenopus oocyte research with drug screening in 96 wells.
• HiClamp Automated system for Xenopus oocyte research using extremely small compound volumes.
• Roboinject Automated injection system for Xenopus oocyte research.
• Transparent 24-well Plate with Gold Electrodes on PET New transparent 24-well plate format for MEA systems with gold electrodes on PET.
• MEA Systems Service Plans Service plans for MEA systems including software updates and support, typically offered as 2-year maintenance packages.

Quantifiable outcome

• Recording capacity from 4 to 4225 channels depending on system configuration
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• Foresee BiosystemscoreStrategic or Co-development PartnerPartnership to combine Foresee Biosystems' IntraCell laser-based optoporation technology with MCS MEA systems. Enables researchers to capture high-quality intracellular action potentials from both 2D cardiac monolayers and 3D cardiac organoids. Sets new standards for intracellular electrophysiology research.
• NMI (Natural and Medical Sciences Institute)coreTechnology or IntegrationLong-standing collaboration with NMI in Reutlingen, Germany for production of FlexMEA products. NMI produces high-quality MEAs using biocompatible materials with established quality controls and production processes refined over many years of collaboration.
• Harvard BiosciencecoreStrategic or Co-development PartnerMulti Channel Systems is a brand within Harvard Bioscience family of companies. Harvard Bioscience combines expertise from over a dozen brands advancing pre-clinical research in cellular and molecular markets. MCS is part of Smart Ephys division alongside HEKA Elektronik and Warner Instruments.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Emerging players

• Neuralink: Neuralink is developing high-channel-count implantable neural recording interfaces for in vivo applications, representing an emerging alternative to MCS's W2100 wireless and ME2100 in vivo electrophysiology systems.

Broad incumbents

• Bruker: Bruker's cellular analysis business (formerly including Cellular Analysis / Fluxion) and broader life-science instruments compete in adjacent electrophysiology and cell-analysis markets served by MCS.
• Thermo Fisher Scientific: Thermo Fisher's analytical instruments and laboratory products divisions include cell-analysis and screening platforms used in similar pharma and academic research workflows as MCS's MEA systems.
• Molecular Devices (Danaher): Molecular Devices offers a broad portfolio including patch clamp amplifiers (Axopatch, MultiClamp) and imaging systems that overlap with MCS's electrophysiology offerings as part of Danaher's larger life-science instrument portfolio.

Direct peers

• Blackrock Microsystems: Blackrock manufactures in vivo electrophysiology recording systems (CerePlex, NeuroPort) used in neuroscience and BCI research, competing with MCS's W2100 wireless and ME2100 in vivo MEA systems.
• Nanion Technologies: Nanion offers automated patch clamp (Port-a-Patch, SyncroPatch) and MEA systems for ion-channel research and cardiotoxicity screening, overlapping with MCS's electrophysiology and drug-safety portfolio.
• Sophion Bioscience: Sophion develops automated patch clamp platforms (QPatch) for ion channel drug discovery, directly competing with MCS's HEKA patch clamp offerings within the Smart Ephys division.
• Axion Biosystems: Axion's Maestro platform is the leading high-throughput MEA system for cardiotoxicity screening and neural assays, directly competing with MCS's Multiwell-MEA-System in pharma drug-safety workflows.
• 3Brain: 3Brain produces CMOS-based high-resolution MEA platforms for in vitro electrophysiology, competing head-to-head with MCS's CMOS-MEA5000 in sub-cellular and network neuroscience applications.
• MaxWell Biosystems: Swiss-based MaxWell Biosystems develops high-density CMOS MEA platforms (MaxOne, MaxTwo) for single-cell and network electrophysiology, directly overlapping with MCS's CMOS-MEA5000 in neuroscience research.

Market position

Strengths5 records

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCMpvBw1UYxcYpKXWkA10x4g
• LinkedInlinkedin.com/company/multi-channel-systems-mcs-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Multi Channel Systems